Literature DB >> 3904752

Expression of cellular oncogenes in human prostatic carcinoma cell lines.

A W Rijnders, J A van der Korput, G J van Steenbrugge, J C Romijn, J Trapman.   

Abstract

Prostatic cancer is one of the most frequent forms of malignancy in Western countries. Initially, growth of the majority of prostate tumors can be manipulated by endocrine therapy. However, ultimately androgen independent tumors continue to grow. We studied the expression of oncogenes in four different human prostatic carcinoma cell lines: PC 3, PC 133, PC 135, which are androgen independent, and the hormone dependent PC 82 cell line. Large amounts of Ha-ras and myc mRNA were present in all cell lines. Transcripts of fes, int-1 and abl were never detected. In some of the cell lines the presence of N-ras, Ki-ras, myb, fos, fms and sis mRNA was observed. The PC 82 cell line showed, in addition to myc and Ha-ras high levels of fos expression. Inhibition of tumor cell proliferation by withdrawal of androgen was accompanied by a tenfold reduction of the fos mRNA level and a twofold reduction of Ha-ras transcripts. In contrast, the expression of myc was not changed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3904752     DOI: 10.1016/0006-291x(85)91168-4

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

Review 1.  Nonreceptor tyrosine kinases in prostate cancer.

Authors:  Yu-Ming Chang; Hsing-Jien Kung; Christopher P Evans
Journal:  Neoplasia       Date:  2007-02       Impact factor: 5.715

Review 2.  Prostate gland: structure, functions and regulation.

Authors:  V L Kumar; P K Majumder
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

3.  A burst of c-fos gene expression in the mouse occurs at birth.

Authors:  J W Kasik; Y J Wan; K Ozato
Journal:  Mol Cell Biol       Date:  1987-09       Impact factor: 4.272

4.  Bcl-2 modulation to activate apoptosis in prostate cancer.

Authors:  Kevin Bray; Hsin-Yi Chen; Cristina M Karp; Michael May; Shridar Ganesan; Vassiliki Karantza-Wadsworth; Robert S DiPaola; Eileen White
Journal:  Mol Cancer Res       Date:  2009-09-08       Impact factor: 5.852

5.  A cell-type specific and enhancer-dependent silencer in the regulation of the expression of the human urokinase plasminogen activator gene.

Authors:  R Cannio; P S Rennie; F Blasi
Journal:  Nucleic Acids Res       Date:  1991-05-11       Impact factor: 16.971

6.  Production of platelet-derived growth factorlike protein(s) by a human carcinoma cell line.

Authors:  K A O'Donnell; M E Condon; A W Hamburger
Journal:  In Vitro Cell Dev Biol       Date:  1989-04

7.  Effects of sex steroids on cell growth and C-myc oncogene expression in LN-CaP and DU-145 prostatic carcinoma cell lines.

Authors:  F K Asadi; R Sharifi
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

Review 8.  Androgen signal transduction and prostatic carcinoma.

Authors:  H Klocker; Z Culig; F Kaspar; A Hobisch; J Eberle; A Reissigl; G Bartsch
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

9.  Stepwise immortalization and transformation of adult human prostate epithelial cells by a combination of HPV-18 and v-Ki-ras.

Authors:  J S Rhim; M M Webber; D Bello; M S Lee; P Arnstein; L S Chen; G Jay
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

10.  Serum level of macrophage colony-stimulating factor is increased in prostate cancer patients with bone metastasis.

Authors:  Hisamitsu Ide; Kiyohiko Hatake; Yuichi Terado; Hiroyuki Tsukino; Takatsugu Okegawa; Kikuo Nutahara; Eiji Higashihara; Shigeo Horie
Journal:  Hum Cell       Date:  2008-02       Impact factor: 4.174

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.